14 November 2024
Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma · Statistically significant and clinically meaningful reduction in the risk of…
14 November 2024 Aviva plc Q3 2024 Trading Update Aviva plc’s Q3 Trading Update for the nine-month period ended 30 September 2024 is available…
14 November 2024 Assura plc Confirmation of secondary listing on the Johannesburg Stock Exchange Assura plc (“Assura” or the “Company”), the UK’s leading diversified…
14 November 2024 Assura plc Interim results: Significant strategic progress in first half of year Assura plc (“Assura”), the UK’s leading diversified healthcare REIT,…
13 November 2024
GlobalData Plc Trading Update Trading In line for FY24 Bolt-on Acquisition of LinkUp GlobalData Plc (‘GlobalData’ or the ‘Group’), a leading data, analytics, and insights…
Strong execution drives good growth in H1 7am, 13 November 2024 ─ Experian plc, the global data and technology company, today issues its financial report…
13 NOVEMBER 2024 FULLER, SMITH & TURNER P.L.C. (“Fuller’s”, the “Company”, or the “Group”) Financial results for the 26 weeks to 28 September 2024…
SSE plc CHIEF EXECUTIVE SUCCESSION 13 November 2024 Alistair Phillips-Davies, Chief Executive of SSE plc, has informed the Board that he intends to retire…